Glucagon Like Peptide-1 (GLP-1) Agonists Market Report

Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 11, 2022
  • PAGES：231
  • REPORT CODE：GMM1364858
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.

    GSK, Eli Lilly, Novo Nordisk, Amylin, AstraZeneca are the leader of the industry, and hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.

    This report elaborates on the current development of the Glucagon Like Peptide-1 (GLP-1) Agonists industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • GSK

    • Eli Lilly

    • Novo Nordisk

    • Amylin

    • AstraZeneca

    • Bristol-Myers Squibb

    • Sanofi

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Exenatied

    • Liraglutide

    • Lixisenatide

    • Albiglutide

    • Dulaglutide

    Application:

    • Hospital

    • Pharmacy

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Overview

      • 1.1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Scope and Market Segments

      • 1.1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Characteristics

      • 1.1.3 Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Production Value and Growth Rate (2017-2028)

    • 1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Exenatied

      • 1.2.2 Liraglutide

      • 1.2.3 Lixisenatide

      • 1.2.4 Albiglutide

      • 1.2.5 Dulaglutide

    • 1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Pharmacy

      • 1.3.3 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Porter's Five Forces Model Analysis

      • 2.2.3 Glucagon Like Peptide-1 (GLP-1) Agonists Industry PEST Analysis

    • 2.3 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Glucagon Like Peptide-1 (GLP-1) Agonists Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Glucagon Like Peptide-1 (GLP-1) Agonists Industry

    Chapter 3 Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Market, by Manufacturer

    • 3.1 Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Market Top 3 Players

    Chapter 4 Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Market, by Type (2017-2028)

    • 4.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Trend, by Type

    • 4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Trend, by Type (2017-2028)

    • 4.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Glucagon Like Peptide-1 (GLP-1) Agonists Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis

    • 7.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market, by Type

    • 7.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market, by Application

    • 7.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis and Forecast, by Country

      • 7.3.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis

    • 8.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market, by Type

    • 8.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market, by Application

    • 8.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis and Forecast, by Country

      • 8.3.1 Germany Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis

    • 9.1 APAC Glucagon Like Peptide-1 (GLP-1) Agonists Market, by Type

    • 9.2 APAC Glucagon Like Peptide-1 (GLP-1) Agonists Market, by Application

    • 9.3 APAC Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis and Forecast, by Country

      • 9.3.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis

    • 10.1 Latin America, Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market, by Type

    • 10.2 Latin America, Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market, by Application

    • 10.3 Latin America, Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Company Profiles

      • 11.1 GSK

        • 11.1.1 GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product Profiles, Application and Specification

        • 11.1.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Eli Lilly

        • 11.2.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Product Profiles, Application and Specification

        • 11.2.3 Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Novo Nordisk

        • 11.3.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Profiles, Application and Specification

        • 11.3.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Amylin

        • 11.4.1 Amylin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product Profiles, Application and Specification

        • 11.4.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 AstraZeneca

        • 11.5.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Profiles, Application and Specification

        • 11.5.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Bristol-Myers Squibb

        • 11.6.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product Profiles, Application and Specification

        • 11.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Sanofi

        • 11.7.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product Profiles, Application and Specification

        • 11.7.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Investment Prospect and Risk Assessment

    • 12.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Value and Growth Rate (2017-2028)

    • Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Production Value and Growth Rate (2017-2028)

    • Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Exenatied (2017-2028)

    • Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Liraglutide (2017-2028)

    • Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Lixisenatide (2017-2028)

    • Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Albiglutide (2017-2028)

    • Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Dulaglutide (2017-2028)

    • Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Pharmacy (2017-2028)

    • Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Other (2017-2028)

    • Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Market Share, by Manufacturer in 2021

    • Figure Global and China Glucagon Like Peptide-1 (GLP-1) Agonists Market Share, by Manufacturer in 2022

    • Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, by Type (2017-2028)

    • Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Type (2017-2028)

    • Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Type (2017-2028)

    • Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value, by Type (2017-2028)

    • Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value Share, by Type (2017-2028)

    • Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Trend, by Type (2017-2028)

    • Table China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, by Type (2017-2028)

    • Table China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Type (2017-2028)

    • Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Type (2017-2028)

    • Table China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value, by Type (2017-2028)

    • Table China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value Share, by Type (2017-2028)

    • Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Price Trend, by Type (2017-2028)

    • Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, by Application (2017-2028)

    • Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Application (2017-2028)

    • Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Application (2017-2028)

    • Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value, by Application (2017-2028)

    • Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value Share, by Application (2017-2028)

    • Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value Share, by Application (2017-2028)

    • Table China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, by Application (2017-2028)

    • Table China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Application (2017-2028)

    • Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Application (2017-2028)

    • Table China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value, by Application (2017-2028)

    • Table China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value Share, by Application (2017-2028)

    • Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value Share, by Application (2017-2028)

    • Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Import, Consumption and Export (2017-2022)

    • Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Glucagon Like Peptide-1 (GLP-1) Agonists Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Production, Import, Consumption and Export (2017-2022)

    • Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, by Type (2017-2028)

    • Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Type (2017-2028)

    • Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Type (2017-2028)

    • Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, by Application (2017-2028)

    • Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Application (2017-2028)

    • Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Application (2017-2028)

    • Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure Canada Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, by Type (2017-2028)

    • Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Type (2017-2028)

    • Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Type (2017-2028)

    • Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, by Application (2017-2028)

    • Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Application (2017-2028)

    • Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Application (2017-2028)

    • Figure Germany Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure UK Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure UK Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure France Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure France Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure Italy Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure Spain Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure Poland Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure Russia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Table APAC Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, by Type (2017-2028)

    • Table APAC Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Type (2017-2028)

    • Figure APAC Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Type (2017-2028)

    • Table APAC Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, by Application (2017-2028)

    • Table APAC Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Application (2017-2028)

    • Figure APAC Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Application (2017-2028)

    • Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Sales Value and Growth Rate (2017-2028)

    • Table GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GSK Product Profiles, Application and Specification

    • Table GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novo Nordisk Product Profiles, Application and Specification

    • Table Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amylin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amylin Product Profiles, Application and Specification

    • Table Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US